{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T17:02:46Z","timestamp":1788627766461,"version":"build-2803163510"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T00:00:00Z","timestamp":1713139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T00:00:00Z","timestamp":1713139200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Radiation necrosis (RN) is a local inflammatory reaction that arises in response to radiation injury and may cause significant morbidity. This study aims to evaluate and compare the efficacy of bevacizumab and laser interstitial thermal therapy (LITT) in treating RN in patients with previously radiated central nervous system (CNS) neoplasms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>PubMed, Cochrane, Scopus, and EMBASE databases were screened. Studies of patients with radiation necrosis from primary or secondary brain tumors were included. Indirect meta-analysis with random-effect modeling was performed to compare clinical and radiological outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Twenty-four studies were included with 210 patients in the bevacizumab group and 337 patients in the LITT group. Bevacizumab demonstrated symptomatic improvement\/stability in 87.7% of cases, radiological improvement\/stability in 86.2%, and steroid wean-off in 45%. LITT exhibited symptomatic improvement\/stability in 71.2%, radiological improvement\/stability in 64.7%, and steroid wean-off in 62.4%. Comparative analysis revealed statistically significant differences favoring bevacizumab in symptomatic improvement\/stability (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.02), while no significant differences were observed in radiological improvement\/stability (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.27) or steroid wean-off (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.90). The rates of adverse reactions were 11.2% for bevacizumab and 14.9% for LITT (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.66), with the majority being grade 2 or lower (72.2% for bevacizumab and 62.5% for LITT).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Both bevacizumab and LITT exhibited favorable clinical and radiological outcomes in managing RN. Bevacizumab was found to be associated with better symptomatic control compared to LITT. Patient-, diagnosis- and lesion-related factors should be considered when choosing the ideal treatment modality for RN to enhance overall patient outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11060-024-04650-1","type":"journal-article","created":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T10:02:22Z","timestamp":1713175342000},"page":"1-11","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Comparative analysis of bevacizumab and LITT for treating radiation necrosis in previously radiated CNS neoplasms: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"168","author":[{"given":"Neslihan Nisa","family":"Gecici","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7141-0654","authenticated-orcid":false,"given":"Muhammet Enes","family":"Gurses","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha L. Frontera","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandler","family":"Berke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif","family":"G\u00f6kalp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor M.","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Ivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo J.","family":"Komotar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish H.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,15]]},"reference":[{"issue":"5","key":"4650_CR1","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.3171\/2022.8.FOCUS22436","volume":"53","author":"A Sahgal","year":"2022","unstructured":"Sahgal A, Sheehan JP, Niranjan A, Chambless LB, Ma L, Trifiletti DM (2022) Introduction. Evolution of radiation therapy techniques. NeuroSurg Focus 53(5):E1","journal-title":"NeuroSurg Focus"},{"issue":"2","key":"4650_CR2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.nec.2022.11.001","volume":"34","author":"APR Terrapon","year":"2023","unstructured":"Terrapon APR, Kr\u00fcger M, Hundsberger T, Neidert MC, Bozinov O (2023) Laser interstitial thermal therapy for Radionecrosis. Neurosurg Clin N Am 34(2):209\u2013225","journal-title":"Neurosurg Clin N Am"},{"issue":"3","key":"4650_CR3","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1159\/000338251","volume":"90","author":"G Rahmathulla","year":"2012","unstructured":"Rahmathulla G, Recinos PF, Valerio JE, Chao S, Barnett GH (2012) Laser interstitial thermal therapy for focal cerebral radiation necrosis: a case report and literature review. Stereotact Funct Neurosurg 90(3):192\u2013200","journal-title":"Stereotact Funct Neurosurg"},{"issue":"4","key":"4650_CR4","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jocn.2012.09.011","volume":"20","author":"G Rahmathulla","year":"2013","unstructured":"Rahmathulla G, Marko NF, Weil RJ (2013) Cerebral radiation necrosis: a review of the pathobiology, diagnosis and management considerations. J Clin Neurosci 20(4):485\u2013502","journal-title":"J Clin Neurosci"},{"issue":"8","key":"4650_CR5","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11912-019-0818-y","volume":"21","author":"FS Ali","year":"2019","unstructured":"Ali FS, Arevalo O, Zorofchian S, Patrizz A, Riascos R, Tandon N et al (2019) Cerebral Radiation necrosis: incidence, Pathogenesis, Diagnostic challenges, and Future opportunities. Curr Oncol Rep 21(8):66","journal-title":"Curr Oncol Rep"},{"issue":"3 Suppl","key":"4650_CR6","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.ijrobp.2009.02.091","volume":"76","author":"YR Lawrence","year":"2010","unstructured":"Lawrence YR, Li XA, el Naqa I, Hahn CA, Marks LB, Merchant TE, Dicker AP (2010) Radiation dose-volume effects in the brain. Int J Radiat Oncol Biol Phys 76(3 Suppl):S20\u2013S27","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"4650_CR7","doi-asserted-by":"crossref","first-page":"6018","DOI":"10.4081\/rt.2015.6018","volume":"7","author":"D Delishaj","year":"2015","unstructured":"Delishaj D, Ursino S, Pasqualetti F, Pesaresi I, Desideri I, Cosottini M et al (2015) The effectiveness of Bevacizumab in Radionecrosis after Radiosurgery of a single brain metastasis. Rare Tumors 7(4):6018","journal-title":"Rare Tumors"},{"issue":"1","key":"4650_CR8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11060-021-03802-x","volume":"154","author":"P Palmisciano","year":"2021","unstructured":"Palmisciano P, Haider AS, Nwagwu CD, Wahood W, Aoun SG, Abdullah KG, El Ahmadieh TY (2021) Bevacizumab vs laser interstitial thermal therapy in cerebral radiation necrosis from brain metastases: a systematic review and meta-analysis. J Neurooncol 154(1):13\u201323","journal-title":"J Neurooncol"},{"key":"4650_CR9","doi-asserted-by":"crossref","first-page":"671867","DOI":"10.3389\/fneur.2021.671867","volume":"12","author":"M Cui","year":"2021","unstructured":"Cui M, Zorrilla-Veloz RI, Hu J, Guan B, Ma X (2021) Diagnostic accuracy of PET for differentiating true glioma progression from Post Treatment-related changes: a systematic review and Meta-analysis. Front Neurol 12:671867","journal-title":"Front Neurol"},{"issue":"3","key":"4650_CR10","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s11060-020-03570-0","volume":"148","author":"N Sujijantarat","year":"2020","unstructured":"Sujijantarat N, Hong CS, Owusu KA, Elsamadicy AA, Antonios JP, Koo AB et al (2020) Laser interstitial thermal therapy (LITT) vs. bevacizumab for radiation necrosis in previously irradiated brain metastases. J Neurooncol 148(3):641\u2013649","journal-title":"J Neurooncol"},{"issue":"18","key":"4650_CR11","first-page":"5950","volume":"63","author":"YQ Li","year":"2003","unstructured":"Li YQ, Chen P, Haimovitz-Friedman A, Reilly RM, Wong CS (2003) Endothelial apoptosis initiates acute blood-brain barrier disruption after ionizing radiation. Cancer Res 63(18):5950\u20135956","journal-title":"Cancer Res"},{"issue":"9","key":"4650_CR12","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/nm749","volume":"8","author":"ML Monje","year":"2002","unstructured":"Monje ML, Mizumatsu S, Fike JR, Palmer TD (2002) Irradiation induces neural precursor-cell dysfunction. Nat Med 8(9):955\u2013962","journal-title":"Nat Med"},{"issue":"3","key":"4650_CR13","doi-asserted-by":"crossref","first-page":"E189","DOI":"10.1093\/neuros\/nyy546","volume":"84","author":"TC Ryken","year":"2019","unstructured":"Ryken TC, Kuo JS, Prabhu RS, Sherman JH, Kalkanis SN, Olson JJ (2019) Congress of Neurological Surgeons Systematic Review and evidence-based guidelines on the role of steroids in the treatment of adults with metastatic brain tumors. Neurosurgery 84(3):E189\u2013E91","journal-title":"Neurosurgery"},{"issue":"11","key":"4650_CR14","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s00066-022-01973-8","volume":"198","author":"D Bernhardt","year":"2022","unstructured":"Bernhardt D, K\u00f6nig L, Grosu A-L, Rieken S, Krieg SM, Wick W et al (2022) DEGRO practical guideline for central nervous system radiation necrosis part 2: treatment. Strahlenther Onkol 198(11):971\u2013980","journal-title":"Strahlenther Onkol"},{"issue":"3","key":"4650_CR15","doi-asserted-by":"crossref","first-page":"589","DOI":"10.3171\/jns.1984.60.3.0589","volume":"60","author":"HV Rizzoli","year":"1984","unstructured":"Rizzoli HV, Pagnanelli DM (1984) Treatment of delayed radiation necrosis of the brain: a clinical observation. J Neurosurg 60(3):589\u2013594","journal-title":"J Neurosurg"},{"key":"4650_CR16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.canlet.2020.05.014","volume":"489","author":"DCA Bastos","year":"2020","unstructured":"Bastos DCA, Weinberg J, Kumar VA, Fuentes DT, Stafford J, Li J et al (2020) Laser interstitial thermal therapy in the treatment of brain metastases and radiation necrosis. Cancer Lett 489:9\u201318","journal-title":"Cancer Lett"},{"issue":"5","key":"4650_CR17","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.ijrobp.2009.12.061","volume":"79","author":"VA Levin","year":"2011","unstructured":"Levin VA, Bidaut L, Hou P, Kumar AJ, Wefel JS, Bekele BN et al (2011) Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system. Int J Radiat Oncol Biol Phys 79(5):1487\u20131495","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"4650_CR18","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13643-021-01626-4","volume":"10","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Reviews 10(1):89","journal-title":"Syst Reviews"},{"issue":"3","key":"4650_CR19","doi-asserted-by":"crossref","first-page":"467","DOI":"10.11124\/JBIES-22-00224","volume":"21","author":"Z Munn","year":"2023","unstructured":"Munn Z, Stone JC, Aromataris E, Klugar M, Sears K, Leonardi-Bee J, Barker TH (2023) Assessing the risk of bias of quantitative analytical studies: introducing the vision for critical appraisal within JBI systematic reviews. JBI Evid Synth 21(3):467\u2013471","journal-title":"JBI Evid Synth"},{"issue":"4","key":"4650_CR20","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1214\/aoms\/1177729756","volume":"21","author":"MF Freeman","year":"1950","unstructured":"Freeman MF, Tukey JW (1950) Transformations related to the angular and the Square Root. Ann Math Stat 21(4):607\u2013611","journal-title":"Ann Math Stat"},{"issue":"3","key":"4650_CR21","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177\u2013188","journal-title":"Control Clin Trials"},{"issue":"4","key":"4650_CR22","first-page":"409","volume":"7","author":"LV Baroni","year":"2020","unstructured":"Baroni LV, Alderete D, Solano-Paez P, Rugilo C, Freytes C, Laughlin S et al (2020) Bevacizumab for pediatric radiation necrosis. Neurooncol Pract 7(4):409\u2013414","journal-title":"Neurooncol Pract"},{"issue":"9","key":"4650_CR23","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1093\/neuonc\/not085","volume":"15","author":"D Boothe","year":"2013","unstructured":"Boothe D, Young R, Yamada Y, Prager A, Chan T, Beal K (2013) Bevacizumab as a treatment for radiation necrosis of brain metastases post stereotactic radiosurgery. Neuro Oncol 15(9):1257\u20131263","journal-title":"Neuro Oncol"},{"issue":"6","key":"4650_CR24","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/CMR.0000000000000389","volume":"27","author":"IC Glitza","year":"2017","unstructured":"Glitza IC, Guha-Thakurta N, D\u2019Souza NM, Amaria RN, McGovern SL, Rao G, Li J (2017) Bevacizumab as an effective treatment for radiation necrosis after radiotherapy for melanoma brain metastases. Melanoma Res 27(6):580\u2013584","journal-title":"Melanoma Res"},{"issue":"2","key":"4650_CR25","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.21037\/apm-20-2417","volume":"10","author":"J Li","year":"2021","unstructured":"Li J, He J, Cai L, Lai M, Hu Q, Ren C et al (2021) Bevacizumab as a treatment for radiation necrosis following stereotactic radiosurgery for brain metastases: clinical and radiation dosimetric impacts. Ann Palliat Med 10(2):2018\u20132026","journal-title":"Ann Palliat Med"},{"issue":"3","key":"4650_CR26","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/COC.0b013e31829c3139","volume":"38","author":"NH Sadraei","year":"2015","unstructured":"Sadraei NH, Dahiya S, Chao ST, Murphy ES, Osei-Boateng K, Xie H et al (2015) Treatment of cerebral radiation necrosis with bevacizumab: the cleveland clinic experience. Am J Clin Oncology: Cancer Clin Trials 38(3):304\u2013310","journal-title":"Am J Clin Oncology: Cancer Clin Trials"},{"issue":"1","key":"4650_CR27","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/2047-783X-17-25","volume":"17","author":"Y Wang","year":"2012","unstructured":"Wang Y, Pan L, Sheng X, Mao Y, Yao Y, Wang E et al (2012) Reversal of cerebral radiation necrosis with bevacizumab treatment in 17 Chinese patients. Eur J Med Res 17(1):25","journal-title":"Eur J Med Res"},{"key":"4650_CR28","doi-asserted-by":"crossref","first-page":"24364","DOI":"10.1038\/srep24364","volume":"6","author":"H Zhuang","year":"2016","unstructured":"Zhuang H, Yuan X, Zheng Y, Li X, Chang JY, Wang J et al (2016) A study on the evaluation method and recent clinical efficacy of bevacizumab on the treatment of radiation cerebral necrosis. Sci Rep 6:24364","journal-title":"Sci Rep"},{"key":"4650_CR29","doi-asserted-by":"crossref","first-page":"8447","DOI":"10.2147\/OTT.S223258","volume":"12","author":"H Zhuang","year":"2019","unstructured":"Zhuang H, Zhuang H, Shi S, Wang Y (2019) Ultra-low-dose Bevacizumab for Cerebral Radiation necrosis: a prospective phase II clinical study. Onco Targets Ther 12:8447\u20138453","journal-title":"Onco Targets Ther"},{"issue":"3","key":"4650_CR30","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/jjco\/hys231","volume":"43","author":"M Furuse","year":"2013","unstructured":"Furuse M, Nonoguchi N, Kawabata S, Yoritsune E, Takahashi M, Inomata T et al (2013) Bevacizumab treatment for symptomatic radiation necrosis diagnosed by amino acid PET. Jpn J Clin Oncol 43(3):337\u2013341","journal-title":"Jpn J Clin Oncol"},{"issue":"2","key":"4650_CR31","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ijrobp.2006.10.010","volume":"67","author":"J Gonzalez","year":"2007","unstructured":"Gonzalez J, Kumar AJ, Conrad CA, Levin VA (2007) Effect of bevacizumab on radiation necrosis of the brain. Int J Radiat Oncol Biol Phys 67(2):323\u2013326","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4650_CR32","doi-asserted-by":"crossref","first-page":"117556","DOI":"10.1016\/j.jns.2021.117556","volume":"427","author":"A Moore","year":"2021","unstructured":"Moore A, Yust-Katz S, Icht O, Eliyahou R, Gordon N, Cohen AY et al (2021) Bevacizumab for stereotactic radiosurgery-induced radiation necrosis in patients with non-small cell lung cancer treated with immune check-point inhibitors. J Neurol Sci 427:117556","journal-title":"J Neurol Sci"},{"issue":"1","key":"4650_CR33","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11060-014-1453-y","volume":"119","author":"S Yonezawa","year":"2014","unstructured":"Yonezawa S, Miwa K, Shinoda J, Nomura Y, Asano Y, Nakayama N et al (2014) Bevacizumab treatment leads to observable morphological and metabolic changes in brain radiation necrosis. J Neurooncol 119(1):101\u2013109","journal-title":"J Neurooncol"},{"issue":"2","key":"4650_CR34","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s11060-019-03097-z","volume":"142","author":"CS Hong","year":"2019","unstructured":"Hong CS, Deng D, Vera A, Chiang VL (2019) Laser-interstitial thermal therapy compared to craniotomy for treatment of radiation necrosis or recurrent tumor in brain metastases failing radiosurgery. J Neurooncol 142(2):309\u2013317","journal-title":"J Neurooncol"},{"issue":"3","key":"4650_CR35","doi-asserted-by":"crossref","first-page":"E338","DOI":"10.1093\/neuros\/nyaa071","volume":"87","author":"AH Kim","year":"2020","unstructured":"Kim AH, Tatter S, Rao G, Prabhu S, Chen C, Fecci P et al (2020) Laser ablation of abnormal neurological tissue using robotic NeuroBlate System (LAANTERN): 12-Month outcomes and Quality of Life after brain tumor ablation. Neurosurgery 87(3):E338\u2013e46","journal-title":"Neurosurgery"},{"issue":"3","key":"4650_CR36","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s11060-018-2828-2","volume":"138","author":"R Rammo","year":"2018","unstructured":"Rammo R, Asmaro K, Schultz L, Scarpace L, Siddiqui S, Walbert T et al (2018) The safety of magnetic resonance imaging-guided laser interstitial thermal therapy for cerebral radiation necrosis. J Neurooncol 138(3):609\u2013617","journal-title":"J Neurooncol"},{"issue":"6","key":"4650_CR37","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1227\/NEU.0000000000000332","volume":"74","author":"MS Rao","year":"2014","unstructured":"Rao MS, Hargreaves EL, Khan AJ, Haffty BG, Danish SF (2014) Magnetic resonance-guided laser ablation improves local control for postradiosurgery recurrence and\/or radiation necrosis. Neurosurgery 74(6):658\u2013667 discussion 67","journal-title":"Neurosurgery"},{"issue":"2","key":"4650_CR38","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/neuros\/nyz424","volume":"87","author":"AH Shah","year":"2020","unstructured":"Shah AH, Semonche A, Eichberg DG, Borowy V, Luther E, Sarkiss CA et al (2020) The role of laser interstitial thermal therapy in Surgical Neuro-Oncology: Series of 100 consecutive patients. Neurosurgery 87(2):266\u2013275","journal-title":"Neurosurgery"},{"issue":"Suppl 1Suppleme","key":"4650_CR39","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1227\/NEU.0000000000001438","volume":"79","author":"CJ Smith","year":"2016","unstructured":"Smith CJ, Myers CS, Chapple KM, Smith KA (2016) Long-term follow-up of 25 cases of biopsy-proven radiation necrosis or post-radiation treatment effect treated with magnetic resonance-guided laser interstitial thermal therapy. Neurosurgery 79(Suppl 1Supplement1):S59\u2013S72","journal-title":"Neurosurgery"},{"issue":"1","key":"4650_CR40","first-page":"vdad031","volume":"5","author":"M Chan","year":"2023","unstructured":"Chan M, Tatter S, Chiang V, Fecci P, Strowd R, Prabhu S et al (2023) Efficacy of laser interstitial thermal therapy for biopsy-proven radiation necrosis in radiographically recurrent brain metastases. Neurooncol Adv 5(1):vdad031","journal-title":"Neurooncol Adv"},{"key":"4650_CR41","doi-asserted-by":"crossref","first-page":"e646","DOI":"10.1016\/j.wneu.2020.01.116","volume":"136","author":"E Luther","year":"2020","unstructured":"Luther E, McCarthy D, Shah A, Semonche A, Borowy V, Burks J et al (2020) Radical laser interstitial thermal therapy ablation volumes increase progression-free survival in Biopsy-Proven Radiation Necrosis. World Neurosurg 136:e646\u2013e59","journal-title":"World Neurosurg"},{"key":"4650_CR42","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1016\/j.wneu.2019.08.242","volume":"132","author":"JI Traylor","year":"2019","unstructured":"Traylor JI, Patel R, Habib A, Muir M, de Almeida Bastos DC, Rao G, Prabhu SS (2019) Laser interstitial thermal therapy to the posterior Fossa: challenges and nuances. World Neurosurg 132:e124\u2013e32","journal-title":"World Neurosurg"},{"issue":"6","key":"4650_CR43","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1227\/neu.0000000000001922","volume":"90","author":"EW Sankey","year":"2022","unstructured":"Sankey EW, Grabowski MM, Srinivasan ES, Griffin AS, Howell EP, Otvos B et al (2022) Time to Steroid Independence after laser interstitial thermal therapy vs Medical Management for treatment of Biopsy-Proven Radiation Necrosis secondary to stereotactic radiosurgery for Brain Metastasis. Neurosurgery 90(6):684\u2013690","journal-title":"Neurosurgery"},{"issue":"3","key":"4650_CR44","doi-asserted-by":"crossref","first-page":"804","DOI":"10.3171\/2017.11.JNS171273","volume":"130","author":"M Ahluwalia","year":"2019","unstructured":"Ahluwalia M, Barnett GH, Deng D, Tatter SB, Laxton AW, Mohammadi AM et al (2019) Laser ablation after stereotactic radiosurgery: a multicenter prospective study in patients with metastatic brain tumors and radiation necrosis. J Neurosurg 130(3):804\u2013811","journal-title":"J Neurosurg"},{"issue":"4","key":"4650_CR45","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/01.nrl.0000080951.78533.c4","volume":"9","author":"P Giglio","year":"2003","unstructured":"Giglio P, Gilbert MR (2003) Cerebral radiation necrosis. Neurologist 9(4):180\u2013188","journal-title":"Neurologist"},{"issue":"3","key":"4650_CR46","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s11060-020-03652-z","volume":"151","author":"C Chen","year":"2021","unstructured":"Chen C, Lee I, Tatsui C, Elder T, Sloan AE (2021) Laser interstitial thermotherapy (LITT) for the treatment of tumors of the brain and spine: a brief review. J Neurooncol 151(3):429\u2013442","journal-title":"J Neurooncol"},{"issue":"1\u20132","key":"4650_CR47","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000314980","volume":"79","author":"S Hapani","year":"2010","unstructured":"Hapani S, Sher A, Chu D, Wu S (2010) Increased risk of Serious Hemorrhage with Bevacizumab in Cancer patients: a Meta-analysis. Oncology 79(1\u20132):27\u201338","journal-title":"Oncology"},{"issue":"9","key":"4650_CR48","first-page":"1451","volume":"40","author":"JI Traylor","year":"2019","unstructured":"Traylor JI, Bastos DCA, Fuentes D, Muir M, Patel R, Kumar VA et al (2019) Dynamic contrast-enhanced MRI in patients with brain metastases undergoing laser interstitial thermal therapy: a pilot study. AJNR Am J Neuroradiol 40(9):1451\u20131457","journal-title":"AJNR Am J Neuroradiol"},{"issue":"1","key":"4650_CR49","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ijrobp.2023.07.015","volume":"118","author":"B Vellayappan","year":"2024","unstructured":"Vellayappan B, Lim-Fat MJ, Kotecha R, De Salles A, Fariselli L, Levivier M et al (2024) A systematic review informing the management of symptomatic Brain Radiation Necrosis after Stereotactic Radiosurgery and International Stereotactic Radiosurgery Society Recommendations. Int J Radiat Oncol Biol Phys 118(1):14\u201328","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-024-04650-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-024-04650-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-024-04650-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T07:05:02Z","timestamp":1715670302000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-024-04650-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,15]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["4650"],"URL":"https:\/\/doi.org\/10.1007\/s11060-024-04650-1","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,15]]},"assertion":[{"value":"28 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}